HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $270,196 | -1.2% | 3,266 | +1.9% | 0.00% | 0.0% |
| Q1 2024 | $273,461 | -51.2% | 3,204 | -51.1% | 0.00% | -50.0% |
| Q4 2023 | $560,689 | -42.2% | 6,557 | -39.4% | 0.00% | -50.0% |
| Q3 2023 | $969,435 | +27.1% | 10,822 | +20.8% | 0.00% | +33.3% |
| Q2 2023 | $762,599 | +418.8% | 8,957 | +298.1% | 0.00% | +200.0% |
| Q2 2022 | $147,000 | -0.7% | 2,250 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $148,000 | +59.1% | 2,335 | +33.4% | 0.00% | 0.0% |
| Q4 2021 | $93,000 | -38.8% | 1,750 | -18.8% | 0.00% | 0.0% |
| Q3 2021 | $152,000 | +10.9% | 2,155 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $137,000 | -38.6% | 2,050 | +2.0% | 0.00% | -50.0% |
| Q1 2021 | $223,000 | +1293.8% | 2,010 | +1388.9% | 0.00% | – |
| Q4 2020 | $16,000 | +33.3% | 135 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | +500.0% | 135 | +440.0% | 0.00% | – |
| Q2 2020 | $2,000 | -33.3% | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |